Clinical Trials Logo
  1. Home
  2. Chronic Renal Disease
  3. NCT01964014

Once-a-day Immunosuppression(CISECON_a_day) — CISECON  

Chronic Renal Disease Clinical Trial

Official title:
Clinical Investigation for Safety and Efficacy, Patient Reported Outcomes of the Conversion to ONce-a-day Immunosuppression After Kidney Transplantation

Clinical Trial Summary

The objective of this study is to assess the efficacy and safety and Immunosuppressant Therapy Barrier Scale (ITBS) of once daily immunosuppressant maintenance therapy in patients who had kidney transplantations earlier.

Clinical Trial Description

This is a 6-month, single-arm, multi-center, open-label, continuous cohort study. 160 subjects who had kidney transplantations at least 3 months earlier will participate in the study. All enrolled subjects will discontinue the existing Tacrolimus preparations for 6 months from enrollment and be converted to Extended Release Tacrolimus at a biologically equivalent dose. They will also discontinue enteric-coated mycophenolate sdium or mycophenolate sodium and be treated with Sirolimus and observed. ;

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01964014
Study type Interventional
Source Ajou University School of Medicine
Contact
Status Completed
Phase Phase 4
Start date October 2013
Completion date October 2015
View Details
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT01155128 - Effects of an Exercise Program in Patients With Hypertensive Chronic Kidney Disease Phase 4
Completed NCT00962000 - Study of How the Dose of Dialysis is Affected by Dialysate Flow Rate N/A
Completed NCT00560014 - Nutrient Levels Alter Transplant Outcome N/A
Completed NCT03274921 - Biomarkers of Cardiovascular Complications in Chronic Kidney Disease
Recruiting NCT01728415 - Effects of High-intensity Interval Training in Patients in Hemodialysis N/A
Completed NCT01532297 - Application of Citrate Dialysate in Chronic Haemodialysis N/A
Completed NCT04100551 - Relationship Between Chronic Renal Disease and Risk Stratification for Chronic Ulcer on the on the Diabetic Foot
Recruiting NCT04428827 - Outcome of Patients With Primary Aldosteronism
Completed NCT02299661 - Pilot PK/PD Study of DS-1093a in Patients With Chronic Kidney Disease Phase 1
Recruiting NCT02190318 - Residual Renal Function Preservation in Peritoneal Dialysis Patients N/A
Terminated NCT01402219 - Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients Phase 4
Not yet recruiting NCT04157647 - Hemadsorption During and After Cardiopulmonary Bypass to Modulate the Inflammatory Response N/A
Completed NCT04897672 - 2D-speckle Tracking in Pediatric Renal Chronic Disease
Terminated NCT02375711 - Immunosenescence and Hepatitis B Virus (HBV) Vaccine Efficacy in Chronic Renal Disease Patient N/A
Not yet recruiting NCT04940819 - A Mobile Application Based Dietary Self Management Intervention in Chinese Chronic Kidney Disease Patients N/A
Completed NCT01817322 - Kidney Graft Function Under the Immunosuppression Strategies Phase 4
Completed NCT05383261 - The Impact of the Social Factors and Rehabilitation Program to Address the Implications on Kidney Failure in Hail
Completed NCT02834026 - Impact of the Cycle Ergometer in Muscle Strength and Pulmonary Function in Patients in Hemodialysis N/A
Completed NCT02072837 - Dyslipidemia-related Risk Factors in Dialysis N/A
Recruiting NCT03425708 - Effect of Hyperuricaemia on Chronic Renal Disease Phase 4